Form: CORRESP

Correspondence

December 2, 2025

 

Profound Medical Corp.

2400 Skymark Avenue, Unit #6

Mississauga, Ontario L4W 5K5

 

December 2, 2025

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

          

Re: Profound Medical Corp.
  Registration Statement on Form S-3
  Filed November 13, 2025
  File No. 333-291516
  Acceleration Request

 

Ladies and Gentlemen:

 

In accordance with Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Profound Medical Corp., a corporation existing under the laws of Ontario, Canada (the “Registrant”), hereby respectfully requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 to Thursday, December 4, 2025, at 4:30 p.m., Eastern time, or as soon as thereafter practicable.

 

The cooperation of the staff in meeting the timetable described above is very much appreciated.

 

Please contact Jeffrey P. Schultz of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6732 with any questions regarding this request.

 

  Very truly yours,
   
  PROFOUND MEDICAL CORP.
   
  /s/ Rashed Dewan
  Rashed Dewan
  Chief Financial Officer

 

  

cc: Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  Jeffrey P. Schultz
  Cheryl V. Reicin
  Eric Foster